Dysregulation of telomere maintenance drives intestinal-type gastric carcinogenesis

Keywords

Telomere / Telomerase / Intestinal subtype / Gastric cancer / Expression profiles

References

[1] Akhavan-Niaki H, Samadani AA. Molecular insight in gastric cancer induction: An overview of cancer stemness genes. Cell Biochemistry and Biophysics, 2014, 68(3): 463-473

[2] Balakrishnan K. Hepatocellular carcinoma stage: An almost loss of fatty acid metabolism and gain of glucose metabolic pathways dysregulation. Medical Oncology, 2022, 39(12): Article ID: 247

[3] Balakrishnan K. Salt-driven chromatin remodeling associated with senescence dysregulation plays a crucial role in the carcinogenesis of gastric cancer subtype. Computational Toxicology, 2023, 25 Article ID: 100262

[4] Balakrishnan K. The hepatocellular carcinoma (HCC) stage carcinogenesis is associated with genomic instability features. Human Gene, 2023, 38 Article ID: 201228

[5] Balakrishnan K. Diffuse subtype-specific gastric carcinogenesis associated with dysregulation of Notch signaling pathways. Genome Instability & Disease, 2024, 5(3): 116-126

[6] Balakrishnan K. Lactate dehydrogenase isoform expressions have differing impacts on gastrointestinal carcinogenesis. Human Gene, 2024, 39 Article ID: 201243

[7] Balakrishnan K. Mitochondrial dysregulation is a key regulator of gastric cancer subtype carcinogenesis. Genome Instability & Disease, 2024

[8] Balakrishnan K. The transcriptional dysregulation of choline catabolism genes was implicated in HCC stage-specific carcinogenesis. Genome Instability & Disease, 2025

[9] Balakrishnan K. Amplified gene expressions were implicated in the gastric carcinogenesis of the intestinal subtype. Genome Instability & Disease, 2026, 7: 6

[10] Balakrishnan K, Chen Y, Dong J. Amplification of Hippo signaling pathway genes is governed and implicated in the serous subtype-specific ovarian carcino-genesis. Cancers, 2024, 16(9): Article ID: 1781

[11] Balakrishnan K, Chen Y, Dong J. Amplified cell cycle genes identified in high-grade serous ovarian cancer. Cancers, 2024, 16(16): Article ID: 2783

[12] Balakrishnan K, Ganesan K. Occurrence of differing metabolic dysregulations, a glucose driven and another fatty acid centric in gastric cancer subtypes. Functional & Integrative Genomics, 2020, 20(6): 813-824

[13] Balakrishnan K, Ganesan K. Identification of oncogenic signaling pathways associated with the dimorphic metabolic dysregulations in gastric cancer subtypes. Medical Oncology, 2022, 39(9): 132

[14] Balakrishnan K, Panneerpandian P, Devanandan HJ, Sekar BT, Rayala SK, Ganesan K. Salt-mediated transcriptional and proteasomal dysregulations mimic the molecular dysregulations of stomach cancer. Toxicology in Vitro: An International Journal Published in Association with BIBRA, 2019, 61 Article ID: 104588

[15] Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, Yefanov A, Lee H, Zhang N, Robertson CL, Serova N, Davis S, Soboleva A. NCBI GEO: Archive for functional genomics data sets—update. Nucleic Acids Research, 2013, 41(Database issue): D991-995

[16] Barthel FP, Wei W, Tang M, Martinez-Ledesma E, Hu X, Amin SB, Akdemir KC, Seth S, Song X, Wang Q, Lichtenberg T, Hu J, Zhang J, Zheng S, Verhaak RGW. Systematic analysis of telomere length and somatic alterations in 31 cancer types. Nature Genetics, 2017, 49(3): 349-357

[17] Blackburn EH. Telomeres. Trends in Biochemical Sciences, 1991, 16(10): 378-381

[18] Bland JM, Altman DG. The logrank test. BMJ, 2004, 328(7447): Article ID: 1073

[19] Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR. Telomere elongation in immortal human cells without detectable telomerase activity. The EMBO Journal, 1995, 14(17): 4240-4248

[20] Chan SRWL, Blackburn EH. Telomeres and telomerase. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 2004, 359(1441): 109-121

[21] Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, Netto GJ, Qin ZS, Kumar S, Manne U, Creighton CJ, Varambally S. UALCAN: An update to the integrated cancer data analysis platform. Neoplasia (New York, N.Y.), 2022, 25: 18-27

[22] Cheadle C, Vawter MP, Freed WJ, Becker KG. Analysis of microarray data using Z score transformation. The Journal of Molecular Diagnostics, 2003, 5(2): 73-81

[23] Chen W, He L-N, Liang Y, Zeng X, Wu C-P, Su M-Q, Cheng Y, Liu J-H. TERF1 downregulation promotes the migration and invasion of the PC3 prostate cancer cell line as a target of miR-155. Molecular Medicine Reports, 2020, 22(6): 5209-5218

[24] de Lange T. Shelterin: The protein complex that shapes and safeguards human telomeres. Genes & Development, 2005, 19(18): 2100-2110

[25] Dinami R, Ercolani C, Petti E, Piazza S, Ciani Y, Sestito R, Sacconi A, Biagioni F, le Sage C, Agami R, Benetti R, Mottolese M, Schneider C, Blandino G, Schoeftner S. miR-155 drives telomere fragility in human breast cancer by targeting TRF1. Cancer Research, 2014, 74(15): 4145-4156

[26] Dos Santos GA, Viana NI, Pimenta R, Guimarães VR, de Camargo JA, Romão P, Reis ST, Leite KRM, Srougi M. Prognostic value of TERF1 expression in prostate cancer. Journal of the Egyptian National Cancer Institute, 2021, 33(1): Article ID: 24

[27] Freedman JA, Tyler DS, Nevins JR, Augustine CK. Use of gene expression and pathway signatures to characterize the complexity of human melanoma. The American Journal of Pathology, 2011, 178(6): 2513-2522

[28] Graham MK, Meeker A. Telomeres and telomerase in prostate cancer development and therapy. Nature Reviews. Urology, 2017, 14(10): 607-619

[29] Győrffy B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innovation (Cambridge (Mass.)), 2024, 5(3): Article ID: 100625

[30] Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell, 2011, 144(5): 646-674

[31] Jelski W, Mroczko B. Molecular and circulating biomarkers of gastric cancer. International Journal of Molecular Sciences, 2022, 23(14): Article ID: 7588

[32] Kuwata T. Molecular classification and intratumoral heterogeneity of gastric adenocarcinoma. Pathology International, 2024, 74(6): 301-316

[33] Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathologica et Microbiologica Scandinavica, 1965, 64: 31-49

[34] Li C, Wong WHParmigiani G, Garrett ES, Irizarry RA, Zeger SL. DNA-chip analyzer (dChip). The analysis of gene expression data: Methods and software, 2003Springer120-141

[35] Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Research, 2020, 48(W1): W509-W514

[36] Liberzon A, Subramanian A, Pinchback R, Thorvaldsdóttir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics (Oxford, England), 2011, 27(12): 1739-1740

[37] Martínez P, Blasco MA. Role of shelterin in cancer and aging. Aging Cell, 2010, 9(5): 653-666

[38] Meyers RM, Bryan JG, McFarland JM, Weir BA, Sizemore AE, Xu H, Dharia NV, Montgomery PG, Cowley GS, Pantel S, Goodale A, Lee Y, Ali LD, Jiang G, Lubonja R, Harrington WF, Strickland M, Wu T, Hawes DC, Zhivich VA, Wyatt MR, Kalani Z, Chang JJ, Okamoto M, Stegmaier K, Golub TR, Boehm JS, Vazquez F, Root DE, Hahn WC, Tsherniak A. Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells. Nature Genetics, 2017, 49(12): 1779-1784

[39] Morales CP, Holt SE, Ouellette M, Kaur KJ, Yan Y, Wilson KS, White MA, Wright WE, Shay JW. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nature Genetics, 1999, 21(1): 115-118

[40] Mushtaq I, Bhat GR, Rah B, Besina S, Zahoor S, Wani MA, Shah MA, Bashir S, Farooq M, Rather RA, Afroze D. Telomere attrition with concomitant hTERT overexpression involved in the progression of gastric cancer may have prognostic and clinical implications in high-risk population group from North India. Frontiers in Oncology, 2022, 12 Article ID: 919351

[41] Nupponen NN, Isola J, Visakorpi T. Mapping the amplification of EIF3S3 in breast and prostate cancer. Genes, Chromosomes & Cancer, 2000, 28(2): 203-210

[42] Rezaei Z, Ranjbaran J, Safarpour H, Nomiri S, Salmani F, Chamani E, Larki P, Brunetti O, Silvestris N, Tavakoli T. Identification of early diagnostic biomarkers via WGCNA in gastric cancer. Biomedicine & Pharmacotherapy, 2022, 145 Article ID: 112477

[43] Shi J, Yang XR, Ballew B, Rotunno M, Calista D, Fargnoli MC, Ghiorzo P, Bressac-de Paillerets B, Nagore E, Avril MF, Caporaso NE, McMaster ML, Cullen M, Wang Z, Zhang XNCI DCEG Cancer Sequencing Working GroupNCI DCEG Cancer Genomics Research LaboratoryFrench Familial Melanoma Study GroupBruno W, Pastorino L, Queirolo P, Banuls-Roca J, Garcia-Casado Z, Vaysse A, Mohamdi H, Riazalhosseini Y, Foglio M, Jouenne F, Hua X, Hyland PL, Yin J, Vallabhaneni H, Chai W, Minghetti P, Pellegrini C, Ravichandran S, Eggermont A, Lathrop M, Peris K, Scarra GB, Landi G, Savage SA, Sampson JN, He J, Yeager M, Goldin LR, Demenais F, Chanock SJ, Tucker MA, Goldstein AM, Liu Y, Landi MT. Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma. Nature Genetics, 2014, 46(5): 482-486

[44] Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA: A Cancer Journal for Clinicians, 2024, 74(1): 12-49

[45] Spinella J-F, Cassart P, Garnier N, Rousseau P, Drullion C, Richer C, Ouimet M, Saillour V, Healy J, Autexier C, Sinnett D. A novel somatic mutation in ACD induces telomere lengthening and apoptosis resistance in leukemia cells. BMC Cancer, 2015, 15 Article ID: 621

[46] Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America, 2005, 102(43): 15545-15550

[47] Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, Doncheva NT, Legeay M, Fang T, Bork P, Jensen LJ, von Mering C. The STRING database in 2021: Customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Research, 2020, 49(D1): D605-D612

[48] Tarca AL, Romero R, Draghici S. Analysis of microarray experiments of gene expression profiling. American Journal of Obstetrics and Gynecology, 2006, 195(2): 373-388

[49] Toussi A, Mans N, Welborn J, Kiuru M. Germline mutations predisposing to melanoma. Journal of Cutaneous Pathology, 2020, 47(7): 606-616

[50] Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C, Sjöstedt E, Asplund A, Olsson IM, Edlund K, Lundberg E, Navani S, Szigyarto CA-K, Odeberg J, Djureinovic D, Takanen JO, Hober S, Alm T, Edqvist P-H, Berling H, Tegel H, Mulder J, Rockberg J, Nilsson P, Schwenk JM, Hamsten M, von Feilitzen K, Forsberg M, Persson L, Johansson F, Zwahlen M, von Heijne G, Nielsen J, Pontén F. Tissue-based map of the human proteome. Science, 2015, 347(6220): Article ID: 1260419

[51] Vahidi S, Norollahi SE, Agah S, Samadani AA. DNA methylation profiling of hTERT gene alongside with the telomere performance in gastric adenocarcinoma. Journal of Gastrointestinal Cancer, 2020, 51(3): 788-799

[52] Wilson CL, Miller CJ. Simpleaffy: A BioConductor package for Affymetrix quality control and data analysis. Bioinformatics, 2005, 21(18): 3683-3685

[53] Wu Z, Gong Z, Li C, Huang Z. RTEL1 is upregulated in colorectal cancer and promotes tumor progression. Pathology, Research and Practice, 2023, 252 Article ID: 154958

[54] Yan M, Zhang Z, Wang L, Huang H, Wang J, Zhu C, Li Z, Xu Z. Cross-talk of three molecular subtypes of telomere maintenance defines clinical characteristics and tumor microenvironment in gastric cancer. Journal of Cancer, 2024, 15(10): 3227-3241

[55] Yang Q, Nie Z, Zhu Y, Hao M, Liu S, Ding X, Wang F, Wang F, Geng X. Inhibition of TRF2 leads to ferroptosis, autophagic death, and apoptosis by causing telomere dysfunction. Oxidative Medicine and Cellular Longevity, 2023, 2023 Article ID: 6897268

[56] Zhang Y, Luo S, Jia Y, Zhang X. Telomere maintenance mechanism dysregulation serves as an early predictor of adjuvant therapy response and a potential therapeutic target in human cancers. International Journal of Cancer, 2022, 151(2): 313-327

RIGHTS & PERMISSIONS

Shenzhen University School of Medicine; Fondazione Istituto FIRC di Oncologia Molecolare